Lamictal licensed for bipolar disorder

Depressive episodes are one of the symptoms of bipolar disorder
Depressive episodes are one of the symptoms of bipolar disorder

Lamictal (lamotrigine) has had its licence extended to include the treatment of bipolar disorder. Both the tablets and the orodispersible tablets may be used in the prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.

The exact mechanism of action of lamotrigine in bipolar disease is unknown, but the anticonvulsant’s interaction with voltage-gated sodium channels is thought to be important.

View Lamictal drug record

Further information: GlaxoSmithKline

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Find alternatives to out-of-stock products with MIMS tables

Find alternatives to out-of-stock products with MIMS tables

With a recent increase in the number of drugs in short...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

New buprenorphine injection allows weekly or monthly treatment of opioid dependence

New buprenorphine injection allows weekly or monthly treatment of opioid dependence

Buvidal (buprenorphine) is licensed for the treatment...

Calcium and Vitamin D Supplements for Osteoporosis

Calcium and Vitamin D Supplements for Osteoporosis

Formulations, doses and costs of osteoporosis supplements.